跳转至内容
Merck
CN
所有图片(2)

主要文件

查看所有文档

安全信息

L2884

Sigma-Aldrich

亮肽素

powder, ≥90% (HPLC)

别名:

亮抑酶肽 半硫酸盐, Acetyl-Leu-Leu-Arg-al, N-乙酰基-L-亮氨酰-L-亮氨酰-L-精氨醛 半硫酸盐

登录查看公司和协议定价
所有图片(2)

About This Item

线性分子式:
C20H38N6O4 · 1/2H2SO4
CAS号:
103476-89-7
分子量:
475.59
MDL编号:
MFCD00037012
UNSPSC代码:
12352202
PubChem化学物质编号:
24896328
NACRES:
NA.77

产品名称

亮肽素, microbial, ≥90% (HPLC)

生物来源

microbial

质量水平

300

方案

≥90% (HPLC)

表单

powder

溶解性

H2O: 10 mM (Solutions are stable for a week at 4 °C. Stock solutions are stable up to 6 months at −20 °C.)
H2O: 50 mg/mL

储存温度

−20°C

SMILES字符串

OS(O)(=O)=O.CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C=O.CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C=O

InChI

1S/2C20H38N6O4.H2O4S/c2*1-12(2)9-16(24-14(5)28)19(30)26-17(10-13(3)4)18(29)25-15(11-27)7-6-8-23-20(21)22;1-5(2,3)4/h2*11-13,15-17H,6-10H2,1-5H3,(H,24,28)(H,25,29)(H,26,30)(H4,21,22,23);(H2,1,2,3,4)/t2*15-,16-,17-;/m00./s1

InChI key

CIPMKIHUGVGQTG-VFFZMTJFSA-N

正在寻找类似产品? 访问 产品对比指南

一般描述

亮肽素或N-乙酰基-L-亮氨酰-L-亮氨酰-L-精氨酸是天然存在的三肽，尤其适合用作丝氨酸蛋白酶抑制剂和半胱氨酸蛋白酶抑制剂。 其作用机理涉及结构相似的共价结合反应：
  • 在丝氨酸蛋白酶的活性位点中，亮肽素在亮肽素的醛基和酶活性位点丝氨酸残基的羟基之间形成共价半缩醛加合物。
  • 在半胱氨酸蛋白酶的活性位点中，亮肽素的亲电子（醛）碳与酶活性位点中半胱氨酸残基的硫原子形成相当的键。

生化/生理作用

丝氨酸和半胱氨酸蛋白酶抑制剂。抑制纤溶酶、胰蛋白酶、木瓜蛋白酶、钙蛋白酶和组织蛋白酶B。不抑制胃蛋白酶、组织蛋白酶A和D、凝血酶或α-糜蛋白酶。有效浓度为10-100 μM.已有许多研究使用亮抑酶肽来预防因听觉过度刺激或耳毒性抗生素庆大霉素引起的听力损失。(耳蜗毛细胞的丧失被认为是由钙蛋白酶介导的。)

分析说明

由于在溶液中形成互变异构异构体，亮抑酶肽在 HPLC 上产生多个峰。大多数污染肽是外消旋亮抑酶肽。

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Gloves, type N95 (US)

法规信息

常规特殊物品

从最新的版本中选择一种：

分析证书(COA)

Lot/Batch Number
0000406505
0000406506
0000394483
0000398608
049M4012V

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Shohreh Majd et al.
BMC cell biology, 19(1), 7-7 (2018-06-21)
Cellular energy failure in high metabolic rate organs is one of the underlying causes for many disorders such as neurodegenerative diseases, cardiomyopathies, liver and renal failures. In the past decade, numerous studies have discovered the cellular axis of LKB1/AMPK/mTOR as
Yang Yang et al.
Journal of dairy science, 100(5), 4014-4024 (2017-03-13)
Adequate lipid synthesis by the mammary gland during lactation is essential for the survival of mammalian offspring. Cell death-inducing DNA fragmentation factor-α-like effector C (CIDEC) is a lipid droplet-associated protein and functions to promote lipid accumulation and inhibit lipolysis in
Philipp A Jaeger et al.
Molecular cell, 69(2), 321-333 (2018-01-21)
We have developed a highly parallel strategy, systematic gene-to-phenotype arrays (SGPAs), to comprehensively map the genetic landscape driving molecular phenotypes of interest. By this approach, a complete yeast genetic mutant array is crossed with fluorescent reporters and imaged on membranes
Wibke Schwarzer et al.
Human molecular genetics, 18(21), 4013-4021 (2009-07-31)
Mutations in ROR2 cause dominant brachydactyly type B (BDB1) or recessive Robinow syndrome (RRS), each characterized by a distinct combination of phenotypic features. We here report a novel nonsense mutation in ROR2 (c.1324C>T; p.R441X) causing intracellular protein truncation in a
Satoshi Nakamura et al.
Scientific reports, 10(1), 12242-12242 (2020-07-24)
Vitamin D deficiency is a recognized risk factor for sarcopenia development, but mechanisms underlying this outcome are unclear. Here, we show that low vitamin D status worsens immobilization-induced muscle atrophy in mice. Mice globally lacking vitamin D receptor (VDR) exhibited
查看所有相关文献

商品

ReadyShield Phosphatase and Protease Inhibitor Cocktail FAQ

ReadyShield® phosphatase and protease inhibitor cocktail FAQ for sample protection in a variety of cell types and tissue extracts, including mammalian, plant, and microbial samples. Our ReadyShield® Protease Inhibitor Cocktail is a non-freezing solution that contains inhibitors with a broad specificity for serine, cysteine, acid proteases and aminopeptidases.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门